Latest Commercialisation News

Patagonia Lithium's latest passive seismic survey at the Formentera Lithium Project has uncovered basement depths up to 800m, doubling previous drilling depths and suggesting expanded lithium brine volumes. Ongoing pump tests confirm strong aquifer flow, underpinning an imminent resource upgrade.

Thrive Tribe Technologies (ASX:1TT) is fast-tracking the relaunch of its legacy HR platforms, WooBoard and REFFIND, integrating AI features to serve enterprise, government, and defense sectors managing dispersed workforces.

NoviqTech's Coralia has kicked off a comprehensive trial converting invasive Chinese Apple trees into biochar at its Great Barrier Reef project, aiming to validate carbon removal methods and support institutional partnerships.

Strategic Elements Ltd has received $1.2 million in applications under its Share Purchase Plan, surpassing its initial $1 million target and raising the cap to $2.5 million. The extra funds will accelerate development of its moisture-powered Energy Ink™ and operational intelligence platform EdgeiQ™.

Recce Pharmaceuticals has signed a non-binding term sheet with a major Middle Eastern pharma player for exclusive rights to commercialise its R327 Topical Gel across the MENA region, targeting a high diabetes burden market.

Beetaloo Energy has wrapped up its $5 million Share Purchase Plan with strong shareholder uptake, pending final approval at the upcoming AGM for new share issuance.

Harvest Technology Group secures a A$6.5 million two-tranche placement to fund its defence strategy, expand Nodestream, and strengthen its balance sheet ahead of key growth initiatives.

Lithium Universe (ASX: LU7) has acquired exclusive global rights to a University of Edinburgh hydrometallurgical process that extracts gold and copper from electronic waste using recyclable organic compounds, positioning the company at the forefront of sustainable precious metals recovery.

Phoslock Environmental Technologies reported a sales recovery in 2025 with further growth expected, backed by resumed production in China and promising European projects, while ongoing litigation clouds the outlook.

Critica Limited’s Jupiter Rare Earth Project pilot plant has delivered a significant beneficiation breakthrough, upgrading feed to a ~3% TREO intermediate concentrate with strong magnet rare earth recoveries and substantial mass rejection.

Biome Australia has launched a multi-centre clinical trial for its proprietary probiotic BMB18, adding a prestigious Greek university to its research network and commencing recruitment within the expected timeline.

EMVision's First Responder Brain Scanner has proven its operational feasibility in aeromedical settings with the Royal Flying Doctor Service, de-risking rural stroke diagnosis and supporting progression to commercial production.